State of Cell Therapy in Multiple Myeloma: Nina Shah, MD

The hematologist and oncologist from University of California, San Francisco discussed the current state of cellular therapy in multiple myeloma.

MD Anderson to Offer Solutions to Cell Therapy AEs

The new technologies were made available as a result of the licensing agreement between MD Anderson and Bellicum Pharmaceuticals.

OpRegen Continues to Show Efficacy in Dry AMD Geographic Atrophy

Lineage Cell Therapeutics announced promising data from interim results of the phase 1/2a clinical trial assessing the cell therapy.

Updated KarMMA Data of Ide-Cel in Multiple Myeloma: Larry D. Anderson Jr, MD, PhD

The associate professor from the Harold C. Simmons Comprehensive Cancer Center of UT Southwestern Medical Center discussed the latest data from the KarMMA trial.

GeneTherapyLive’s Weekly Rewind – September 17, 2021

Review top news and interview highlights from the week ending September 17, 2021.

Cell Therapy for Critical Limb Ischemia Shows Positive Interim Data

An interim analysis has met prespecified safety and efficacy checkpoints.